Skip to main content
John Sunwoo, MD, Otolaryngology (ENT), Palo Alto, CA

JohnBingSunwooMD

Otolaryngology (ENT) • Palo Alto, CA

Head & Neck Oncologic Surgery, Head & Neck Plastic Surgery

Edward C. and Amy H. Sewall Professor and Associate Dean for Academic Affairs at Stanford University

Join to view full profile

Dr. Sunwoo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sunwoo's full profile

Already have an account?

  • Office

    300 Pasteur Dr
    # MC5500
    Palo Alto, CA 94305
    Phone+1 650-498-6000
    Fax+1 650-498-5840

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Otolaryngology - Head and Neck Surgery, 1997 - 2003
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1993

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2008 - 2026
  • MD State Medical License
    MD State Medical License 1998 - 2001
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Fellow (FACS) American College of Surgeons
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • A Novel Cross-Correlation Methodology for Assessing Biophysical Responses Associated with Pain  
    Lonnie K Zeltzer, Roberta M Kato, Jon Detterich, Thomas D Coates, John Sunwoo, John C Wood, Journal of Pain Research

Press Mentions

  • Heavy Cannabis Use Linked to High Risk of Head, Neck Cancers
    Heavy Cannabis Use Linked to High Risk of Head, Neck CancersAugust 12th, 2024
  • Indapta Therapeutics Announces New Preclinical Data Demonstrating Proprietary G-NK Cells Enhance Efficacy of Monoclonal Antibodies in Multiple Myeloma
    Indapta Therapeutics Announces New Preclinical Data Demonstrating Proprietary G-NK Cells Enhance Efficacy of Monoclonal Antibodies in Multiple MyelomaAugust 10th, 2021

Professional Memberships

Dr. John Sunwoo, Dr. John Sunwoo, MD, Dr. J Sunwoo, Dr. John Bing Sunwoo